• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2019冠状病毒病感染后的休止期脱发:113例回顾性研究

Telogen Effluvium Following Coronavirus Disease-2019 Infection: A Retrospective Study of 113 Cases.

作者信息

Chhabra Namrata, George C Anju, Ganguly Satyaki

机构信息

Department of Dermatology, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India.

出版信息

Int J Trichology. 2025 Jan-Feb;17(1):32-35. doi: 10.4103/ijt.ijt_38_22. Epub 2025 Jun 23.

DOI:10.4103/ijt.ijt_38_22
PMID:40654560
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12252012/
Abstract

BACKGROUND

Telogen effluvium (TE) is self limiting diffuse hair loss occurring 3-4 months after a triggering event. There is scarcity of data on TE as possible sequelae of COVID-19.

METHODS

We assessed 113 cases of TE occurring after SARS-CoV-2 infection as a retrospective study.

RESULTS

Most of the patients belonged to the age group 18-30 years and were females (85.8%). Most of the patients (92%) had acute TE. The median duration of hair loss was 2 months. Trichodynia and pruritus were the common associated complaints. Hair pull test was positive in 54.9% patients. Trichoscopy showed short regrowing hairs in 61.2% patients and empty hair follicles in 77.9% patients. Ferritin, vitamin D and Vitamin B12 deficiency was seen in 27.4%, 38.1% and 20.4% patients respectively. TE was seen more commonly with symptomatic COVID infection (93% patients).

CONCLUSION

TE occurring after SARS-CoV-2 infection calls for assessment of micronutrient deficiency, as there appears to be an association between COVID-19 infection and nutritional deficiency. Although acute TE is the most common presentation, relapse in chronic TE might also occur as sequelae of COVID-19 infection.

摘要

背景

休止期脱发(TE)是一种自限性弥漫性脱发,发生在触发事件后的3 - 4个月。关于TE作为新冠病毒病可能后遗症的数据较少。

方法

我们进行了一项回顾性研究,评估了113例新冠病毒感染后发生的休止期脱发病例。

结果

大多数患者年龄在18 - 30岁之间,且为女性(85.8%)。大多数患者(92%)患有急性休止期脱发。脱发的中位持续时间为2个月。毛发疼痛和瘙痒是常见的相关主诉。54.9%的患者拔毛试验呈阳性。毛发镜检查显示,61.2%的患者有短的再生毛发,77.9%的患者有毛囊空虚。分别有27.4%、38.1%和20.4%的患者存在铁蛋白、维生素D和维生素B12缺乏。休止期脱发在有症状的新冠病毒感染患者中更常见(93%的患者)。

结论

新冠病毒感染后发生的休止期脱发需要评估微量营养素缺乏情况,因为新冠病毒感染与营养缺乏之间似乎存在关联。虽然急性休止期脱发是最常见的表现,但慢性休止期脱发复发也可能作为新冠病毒感染的后遗症出现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/323e/12252012/44648cdbbd58/IJT-17-32-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/323e/12252012/29ea4939d124/IJT-17-32-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/323e/12252012/1e7bac38e073/IJT-17-32-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/323e/12252012/44648cdbbd58/IJT-17-32-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/323e/12252012/29ea4939d124/IJT-17-32-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/323e/12252012/1e7bac38e073/IJT-17-32-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/323e/12252012/44648cdbbd58/IJT-17-32-g003.jpg

相似文献

1
Telogen Effluvium Following Coronavirus Disease-2019 Infection: A Retrospective Study of 113 Cases.2019冠状病毒病感染后的休止期脱发:113例回顾性研究
Int J Trichology. 2025 Jan-Feb;17(1):32-35. doi: 10.4103/ijt.ijt_38_22. Epub 2025 Jun 23.
2
Oral Supplementation with l-Cystine, , , and in Chronic Telogen Effluvium and Androgenetic Alopecia: A Double-Blind, Placebo-Controlled, Randomized Clinical Study.口服补充L-胱氨酸、[此处可能有其他成分未列出]、[此处可能有其他成分未列出]治疗慢性休止期脱发和雄激素性脱发:一项双盲、安慰剂对照、随机临床研究。
Skin Appendage Disord. 2025 Feb;11(1):27-35. doi: 10.1159/000540081. Epub 2024 Jul 26.
3
Use of 5% Topical Minoxidil Application for Telogen Effluvium: An Open-Label Single-Arm Clinical Trial.5%外用米诺地尔治疗休止期脱发:一项开放标签单臂临床试验
J Dermatol. 2025 Sep;52(9):1351-1359. doi: 10.1111/1346-8138.17844. Epub 2025 Jul 2.
4
The effect of sample site and collection procedure on identification of SARS-CoV-2 infection.样本采集部位和采集程序对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染鉴定的影响。
Cochrane Database Syst Rev. 2024 Dec 16;12(12):CD014780. doi: 10.1002/14651858.CD014780.
5
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
6
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
7
Pharmacological intervention for irritability, aggression, and self-injury in autism spectrum disorder (ASD).自闭症谱系障碍(ASD)中易怒、攻击行为和自我伤害的药物干预。
Cochrane Database Syst Rev. 2023 Oct 9;10(10):CD011769. doi: 10.1002/14651858.CD011769.pub2.
8
Effectiveness and safety of vitamin D in relation to bone health.维生素D对骨骼健康的有效性与安全性。
Evid Rep Technol Assess (Full Rep). 2007 Aug(158):1-235.
9
Measures implemented in the school setting to contain the COVID-19 pandemic.学校为控制 COVID-19 疫情而采取的措施。
Cochrane Database Syst Rev. 2022 Jan 17;1(1):CD015029. doi: 10.1002/14651858.CD015029.
10
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.

本文引用的文献

1
COVID-19 infection is a major cause of acute telogen effluvium.COVID-19 感染是急性休止期脱发的主要原因。
Ir J Med Sci. 2022 Aug;191(4):1677-1681. doi: 10.1007/s11845-021-02754-5. Epub 2021 Aug 31.
2
Trichodynia and telogen effluvium in COVID-19 patients: Results of an international expert opinion survey on diagnosis and management.新冠病毒感染患者的拔毛癖和休止期脱发:一项关于诊断和管理的国际专家意见调查结果
JAAD Int. 2021 Dec;5:11-18. doi: 10.1016/j.jdin.2021.07.006. Epub 2021 Aug 3.
3
Telogen effluvium: a sequela of COVID-19.休止期脱发:新冠病毒病的后遗症。
Int J Dermatol. 2021 Jan;60(1):122-124. doi: 10.1111/ijd.15313. Epub 2020 Nov 23.
4
SARS-CoV-2-induced telogen effluvium: a multicentric study.严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)诱发的休止期脱发:一项多中心研究。
J Eur Acad Dermatol Venereol. 2021 Mar;35(3):e181-e183. doi: 10.1111/jdv.17045. Epub 2020 Dec 9.
5
Telogen effluvium related to post severe Sars-Cov-2 infection: Clinical aspects and our management experience.与严重 SARS-CoV-2 感染后相关的休止期脱发:临床特征和我们的治疗经验。
Dermatol Ther. 2021 Jan;34(1):e14547. doi: 10.1111/dth.14547. Epub 2020 Nov 23.
6
Acute telogen effluvium associated with SARS-CoV-2 infection.急性休止期脱发与 SARS-CoV-2 感染相关。
Aust J Gen Pract. 2020 Aug 26;49. doi: 10.31128/AJGP-COVID-32.
7
Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study.中国武汉 COVID-19 幸存者的临床后遗症:一项单中心纵向研究。
Clin Microbiol Infect. 2021 Jan;27(1):89-95. doi: 10.1016/j.cmi.2020.09.023. Epub 2020 Sep 23.
8
Traditional Anticoagulants and Hair Loss: A Role for Direct Oral Anticoagulants? A Review of the Literature.传统抗凝剂与脱发:直接口服抗凝剂是否有作用?文献综述
Drugs Real World Outcomes. 2016 Mar;3(1):1-6. doi: 10.1007/s40801-015-0056-z.
9
Telogen Effluvium: A Review.休止期脱发:综述
J Clin Diagn Res. 2015 Sep;9(9):WE01-3. doi: 10.7860/JCDR/2015/15219.6492. Epub 2015 Sep 1.
10
Telogen effluvium. New concepts and review.休止期脱发。新概念与综述。
Arch Dermatol. 1993 Mar;129(3):356-63. doi: 10.1001/archderm.129.3.356.